Business Description
Arvee Laboratories (India) Ltd
ISIN : INE006Z01016
Share Class Description:
NSE:ARVEE: Ordinary SharesTotal Employee Number:
70Compare
Compare
Traded in other countries / regions
ARVEE.India IPO Date
2018-02-22Description
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.66 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.35 | |||||
Interest Coverage | 9.19 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 12.44 | |||||
Beneish M-Score | -1.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EBITDA Growth Rate | -12.1 | |||||
3-Year EPS without NRI Growth Rate | -5.7 | |||||
3-Year FCF Growth Rate | -7 | |||||
3-Year Book Growth Rate | 9.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.93 | |||||
9-Day RSI | 46.45 | |||||
14-Day RSI | 45.75 | |||||
3-1 Month Momentum % | -1.46 | |||||
6-1 Month Momentum % | 5.53 | |||||
12-1 Month Momentum % | -4.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.52 | |||||
Quick Ratio | 1.84 | |||||
Cash Ratio | 1.01 | |||||
Days Inventory | 162.57 | |||||
Days Sales Outstanding | 92.66 | |||||
Days Payable | 111.18 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 45.05 | |||||
Operating Margin % | 4.25 | |||||
Net Margin % | 7.65 | |||||
EBITDA Margin % | 10.93 | |||||
FCF Margin % | -7.6 | |||||
OCF Margin % | -0.76 | |||||
ROE % | 6.64 | |||||
ROA % | 5.27 | |||||
ROIC % | 4.09 | |||||
3-Year ROIIC % | -10.89 | |||||
ROC (Joel Greenblatt) % | 6.91 | |||||
ROCE % | 5.35 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 85.62 | |||||
PE Ratio without NRI | 89.83 | |||||
Shiller PE Ratio | 64.25 | |||||
PS Ratio | 6.52 | |||||
PB Ratio | 5.17 | |||||
Price-to-Tangible-Book | 5.03 | |||||
EV-to-EBIT | 92.93 | |||||
EV-to-EBITDA | 56.29 | |||||
EV-to-Revenue | 6.16 | |||||
EV-to-FCF | -79.36 | |||||
Price-to-GF-Value | 1.27 | |||||
Price-to-Projected-FCF | 3.9 | |||||
Price-to-Graham-Number | 11.36 | |||||
| Price-to-Net-Current-Asset-Value | 10.59 | |||||
Earnings Yield (Greenblatt) % | 1.08 | |||||
FCF Yield % | -1.2 | |||||
Forward Rate of Return (Yacktman) % | -11.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvee Laboratories (India) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 271.112 | ||
| EPS (TTM) (₹) | 1.88 | ||
| Beta | 1.6592 | ||
| 3-Year Sharpe Ratio | 0.31 | ||
| 3-Year Sortino Ratio | 0.65 | ||
| Volatility % | 54.76 | ||
| 14-Day RSI | 45.75 | ||
| 14-Day ATR (₹) | 8.530235 | ||
| 20-Day SMA (₹) | 158.4305 | ||
| 12-1 Month Momentum % | -4.35 | ||
| 52-Week Range (₹) | 129.11 - 290.78 | ||
| Shares Outstanding (Mil) | 11.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arvee Laboratories (India) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arvee Laboratories (India) Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2020-10-13 | 39.88 (+0.00%) |
Show
Entries
Arvee Laboratories (India) Ltd Frequently Asked Questions
What is Arvee Laboratories (India) Ltd(NSE:ARVEE)'s stock price today?
The current price of NSE:ARVEE is ₹156.72. The 52 week high of NSE:ARVEE is ₹290.78 and 52 week low is ₹129.11.
When is next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE)?
The next earnings date of Arvee Laboratories (India) Ltd(NSE:ARVEE) is .
Does Arvee Laboratories (India) Ltd(NSE:ARVEE) pay dividends? If so, how much?
Arvee Laboratories (India) Ltd(NSE:ARVEE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arvee Laboratories (India) Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers